These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 146607)

  • 1. Cell-mediated immunity in canine marrow graft recipients given cyclophosphamide.
    Abb J; Kolb HJ; Grosse-Wilde H; Reider I; Thierfelder S
    Exp Hematol; 1978 Jan; 6(1):58-66. PubMed ID: 146607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo immune response to specific antigens in canine marrow graft recipients.
    Abb J; Kolb HJ; Rodt HV; Grosse-Wilde H; Rieder I; Thierfelder S
    Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):152-61. PubMed ID: 71795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
    Tsoi MS; Storb R; Weiden PL; Graham TC; Schroeder ML; Thomas ED
    J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organ tolerance and incomplete bone marrow chimera in dogs].
    von Scheel J; Kolb HJ; Chaussy C; Rieder I; Duswald KH; Pielsticker K
    Chir Forum Exp Klin Forsch; 1977 Apr; ():274-8. PubMed ID: 376244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras.
    Storb R; Tsoi MS; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1976 Dec; 8(4):561-4. PubMed ID: 11587
    [No Abstract]   [Full Text] [Related]  

  • 11. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
    Klingemann HG; Kohn FR; Phillips GL
    Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation following treatment with cyclophosphamide and bone marrow grafting.
    von Scheel J; Kolb HJ; Duswald KH; Rieder I; Chaussy C; Grosse-Wilde H; Scholz S; Pielsticker K
    Transplant Proc; 1977 Mar; 9(1):261-3. PubMed ID: 325763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCID mouse as a model for transplantation studies.
    Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
    J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the immune response in experimental models of autoimmune disorders: I. Immunocompetence and transplantation tolerance in female (NZB X NZW)F1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras.
    Moscovitch M; Slavin S
    J Clin Lab Immunol; 1983 Apr; 10(4):185-91. PubMed ID: 6345783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.